The firm urges investors in LifeMD who suffered significant losses to submit your losses now. The alleged deception unraveled on August 5, 2025, when LifeMD announced its second-quarter results, missing revenue and earnings per share estimates and subsequently slashing its full-year guidance. For investors who suffered substantial losses during this period, the lawsuit represents an opportunity to recover damages. "We're investigating whether LifeMD knew of but failed to disclose key operational problems," said Reed Kathrein, the Hagens Berman partner leading the investigation. # # #About Hagens BermanHagens Berman is a global plaintiffs' rights complex litigation firm focusing on corporate accountability.